• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2013 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [The effectiveness of occupational therapy for persons with moderate and severe dementia]
2013 NIHR Health Technology Assessment programme Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project
2013 NIHR Health Technology Assessment programme SeHCAT (Tauroselcholic [75 selenium] acid) for the investigation of bile acid malabsorption (BAM) and measurement of bile acid pool loss
2013 NIHR Health Technology Assessment programme Screening for type 2 diabetes: a short report for the National Screening Committee
2013 NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of depth of anaesthesia monitoring (E-Entropy, Bispectral Index and Narcotrend): a systematic review and economic evaluation
2013 NIHR Health Technology Assessment programme Rapid fetal fibronectin (fFN) testing to predict pre-term birth in women with symptoms of premature labour: A systematic review and cost-effectiveness analysis
2013 NIHR Health Technology Assessment programme Pirfenidone for the treatment of idiopathic pulmonary fibrosis
2013 NIHR Health Technology Assessment programme Ivabradine for the treatment of chronic heart failure
2013 NIHR Health Technology Assessment programme Fluocinolone acetonide intravitreal implant for the treatment of chronic diabetic macular oedema
2013 Health Information and Quality Authority (HIQA) Health technology assessment (HTA) of surveillance of women aged less than 50 years at elevated risk of breast cancer
2013 Adelaide Health Technology Assessment (AHTA) Australian guidelines for the treatment of acute stress disorder and posttraumatic stress disorder
2013 Institut national d'excellence en sante et en services sociaux (INESSS) [Assessment of the PARLER (Programme d'Accès Rapide Lavallois en Rhumatologie) program]
2013 Institut national d'excellence en sante et en services sociaux (INESSS) [The efficacy of rehabilitative interventions and pharmacological treatments for children aged 2 to 12 years with autism spectrum disorder (ASD)]
2013 Institut national d'excellence en sante et en services sociaux (INESSS) [Advisability of expanding the Québec newborn blood screening program]
2013 Institut national d'excellence en sante et en services sociaux (INESSS) [Use of medullary neurostimulators for the treatment of chronic non-cancer pain]
2013 NIHR Horizon Scanning Centre (NIHR HSC) Abraxane in combination with gemcitabine for metastatic pancreatic cancer – first line
2013 NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for relapsed platinum-resistant ovarian cancer – second line
2013 NIHR Horizon Scanning Centre (NIHR HSC) Erismodegib for locally advanced or metastatic basal cell carcinoma
2013 NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) for the adjuvant treatment of EGFR positive non-small cell lung cancer
2013 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Renal sympathetic denervation as treatment of resistant hypertension]
2013 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Canaloplasty for open angle glaucoma]
2013 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) for corneal endothelial dysfunction]
2013 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Neonatal screening of sickle cell anemia]
2013 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Automated reading methods of uterine cervical cytology]
2013 NIHR Horizon Scanning Centre (NIHR HSC) Trebananib in combination with chemotherapy for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer
2013 NIHR Horizon Scanning Centre (NIHR HSC) Tertomotide for locally advanced or metastatic pancreatic cancer
2013 NIHR Horizon Scanning Centre (NIHR HSC) Ospemifene for vulvo-vaginal atrophy in postmenopausal women
2013 NIHR Horizon Scanning Centre (NIHR HSC) Avatrombopag for immune (idiopathic) thrombocytopenic purpura
2013 NIHR Horizon Scanning Centre (NIHR HSC) Preladenant for Parkinson's disease – monotherapy or adjunct to levodopa therapy
2013 NIHR Horizon Scanning Centre (NIHR HSC) Dexamethasone intraocular injection (Verisome) for prevention and treatment of post-ocular surgery inflammation
2013 NIHR Horizon Scanning Centre (NIHR HSC) Intravitreal sirolimus (Opsiria) for chronic non-infectious posterior segment uveitis – first or second line
2013 NIHR Horizon Scanning Centre (NIHR HSC) Lesinurad for gout
2013 NIHR Horizon Scanning Centre (NIHR HSC) Apremilast for psoriasis
2013 NIHR Horizon Scanning Centre (NIHR HSC) Apremilast for psoriatic arthritis
2013 NIHR Horizon Scanning Centre (NIHR HSC) Phagenyx™ for stroke-induced dysphagia
2013 NIHR Health Technology Assessment programme Pragmatic cluster randomised trial of PhysioDirect telephone assessment and advice services for physiotherapy
2013 The Regional Health Technology Assessment Centre (HTA-centrum) Renal sympathetic denervation in patients with therapy resistant hypertension
2013 Health Technology and Policy Unit (HTPU) Level I and level III sleep studies for the diagnosis of sleep disordered breathing (SDB) in adults
2013 Agency for Healthcare Research and Quality (AHRQ) Assessment and management of chronic cough
2013 Agency for Healthcare Research and Quality (AHRQ) Outpatient case management for adults with medical illness and complex care needs
2013 Agency for Healthcare Research and Quality (AHRQ) Child and adolescent exposure to trauma: comparative effectiveness of interventions addressing trauma other than maltreatment or family violence
2013 Agency for Healthcare Research and Quality (AHRQ) Intravascular diagnostic procedures and imaging techniques versus angiography alone in coronary artery stenting: comparative effectiveness review
2013 Agency for Healthcare Research and Quality (AHRQ) Insulin delivery and glucose monitoring methods: future research needs
2013 Agency for Healthcare Research and Quality (AHRQ) Efficacy and safety of screening for postpartum depression
2013 Agency for Healthcare Research and Quality (AHRQ) Technology assessment on genetic testing or molecular pathology testing of cancers with unknown primary site to determine origin
2013 Agency for Healthcare Research and Quality (AHRQ) Fluorescence In Situ Hybridization (FISH) or Other In Situ Hybridization (ISH) testing of uterine cervical cells to predict precancer and cancer
2013 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Colorectal-cancer-screening update; status in Austria and European countries; and quality assurance of screening-colonoscopy]
2013 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Marketing authorisations under exceptional circumstances for oncology drugs: an analysis of approval and reimbursement decisions of four drugs
2013 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Crizotinib (Xalkori®) for the treatment of anaplastic lymphoma kinase (ALK) positive advanced non-small cell lung cancer (NSCLC)
2013 HAYES, Inc. Continuous passive motion for the treatment of joint contractures of the extremities
2013 HAYES, Inc. Epidural steroid injections for low back pain and sciatica
2013 HAYES, Inc. Laparoscopic CO2 laser ablation for endometriosis
2013 HAYES, Inc. Magnetic resonance elastography for detecting and staging liver fibrosis
2013 HAYES, Inc. Mechanical stretching devices for the treatment of joint contractures of the extremities
2013 HAYES, Inc. Percutaneous left atrial appendage closure to reduce stroke risk in patients with atrial fibrillation
2013 HAYES, Inc. Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for the posttreatment management of cancer of the head and neck
2013 HAYES, Inc. Serological assays for the diagnosis and management of inflammatory bowel disease: crohn's disease
2013 HAYES, Inc. Simultaneous pancreas-kidney (SPK) transplantation in diabetic patients
2013 HAYES, Inc. Testosterone for low sexual desire in nonsurgically postmenopausal women
2013 HAYES, Inc. Transradial, transbrachial, and transulnar approaches for coronary angiography and intervention
2013 HAYES, Inc. BRAF p.Val600Glu testing in papillary thyroid carcinoma
2013 HAYES, Inc. Ehlers-danlos syndrome (EDS), classic type
2013 HAYES, Inc. Familial mediterranean fever (FMF)
2013 HAYES, Inc. Interleukin 28B (IL28B) testing to predict response to treatment of hepatitis C virus (HCV) infection
2013 HAYES, Inc. Kabuki syndrome
2013 HAYES, Inc. PreOvar KRAS-variant test for ovarian cancer
2013 HAYES, Inc. C-leg prostheses (Otto Bock HealthCare LP) for patients with above-knee amputation
2013 HAYES, Inc. Coflex interlaminar stabilization device (Paradigm Spine LLC) for treatment of lumbar spinal stenosis
2013 HAYES, Inc. CyberKnife robotic radiosurgery system (Accuray Inc.) for treatment of prostate cancer
2013 HAYES, Inc. Impella recover LP 2.5 percutaneous cardiac support system (Abiomed Inc.) for patients undergoing high-risk percutaneous coronary intervention (PCI)
2013 HAYES, Inc. iStent trabecular micro-bypass stent (Glaukos Corp.) for treatment of primary open-angle glaucoma
2013 HAYES, Inc. MindStreams cognitive health assessment (NeuroTrax Corp.) product suite (U.S. Clinical Edition) for assessing mild cognitive impairment
2013 HAYES, Inc. Preoperative whole-body bathing with chlorhexidine gluconate 4% for prevention of surgical site infection
2013 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Insulin glargine (Lantus®) 100 units/ml solution for injection
2013 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) C1 inhibitor (Cinryze®) 500 units powder and solvent for solution for injection
2013 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Vildagliptin (Galvus®) 50 mg tablets
2013 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Racecadotril (Hidrasec®) 10 mg and 30 mg granules for oral suspension
2013 The Swedish Council on Health Technology Assessment (SBU) [Continuous subcutaneous glucose monitoring for diabetes]
2013 The Swedish Council on Health Technology Assessment (SBU) [Treatment duration for Lyme disease]
2013 The Swedish Council on Health Technology Assessment (SBU) [Emergency care for the elderly patients who are in the poorest health]
2013 The Swedish Council on Health Technology Assessment (SBU) [Urinary incontinence in the elderly]
2013 NIHR Horizon Scanning Centre (NIHR HSC) Glysure intravascular continuous glucose monitoring system for glycaemic control in intensive care
2013 NIHR Horizon Scanning Centre (NIHR HSC) Afatinib for locally advanced, recurrent or metastatic head and neck squamous cell carcinoma – second line
2013 NIHR Horizon Scanning Centre (NIHR HSC) Astuprotimut-r (Zumagev) for stage III, MAGE-A3 positive malignant melanoma – adjuvant therapy
2013 NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib (Tyverb) for HER2-positive breast cancer – adjuvant therapy in combination with or following trastuzumab
2013 NIHR Horizon Scanning Centre (NIHR HSC) LDK378 for ALK-activated advanced non-small cell lung cancer – second and subsequent lines
2013 NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab (Arzerra) for relapsed diffuse large B-cell lymphoma
2013 NIHR Horizon Scanning Centre (NIHR HSC) Orteronel for metastatic hormone-relapsed prostate cancer following chemotherapy
2013 NIHR Horizon Scanning Centre (NIHR HSC) TK cell therapy for acute leukaemia patients who are candidate to haematopoietic stem cell transplantation – adjunct therapy
2013 NIHR Horizon Scanning Centre (NIHR HSC) Volasertib for acute myeloid leukaemia in patients ineligible for intensive induction therapy – first line
2013 NIHR Horizon Scanning Centre (NIHR HSC) POST-C saliva test for suspected oral cancer
2013 NIHR Horizon Scanning Centre (NIHR HSC) UPDATED: Caris Target Now™ molecular profiling service for solid malignant tumours
2013 NIHR Horizon Scanning Centre (NIHR HSC) AMG 145 for hyperlipidaemia and mixed dyslipidaemia
2013 NIHR Horizon Scanning Centre (NIHR HSC) Cangrelor for prevention of coronary thrombosis in patients undergoing cardiovascular surgery
2013 NIHR Horizon Scanning Centre (NIHR HSC) Ularitide for acute decompensated heart failure – first line
2013 NIHR Horizon Scanning Centre (NIHR HSC) AngelMed Guardian® System for detection of myocardial infarction
2013 NIHR Horizon Scanning Centre (NIHR HSC) Parachute® Implant System for ischaemic heart failure
2013 NIHR Horizon Scanning Centre (NIHR HSC) T30 neurostimulator device for chronic tonal subjective tinnitus
2013 Andalusian Health Technology Assessment Area (AETSA) [Tumor treating fields therapy (TTF) for glioblastoma. A systematic review of the literature]
2013 Medical Advisory Secretariat (MAS) Transcatheter Aortic Valve Implantation (TAVI) for treatment of aortic valve stenosis: an evidence update